Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-328763
Filing Date
2020-12-29
Accepted
2020-12-29 17:15:22
Documents
64
Period of Report
2020-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q d49187d10q.htm   iXBRL 10-Q 1205555
2 EX-31.1 d49187dex311.htm EX-31.1 10643
3 EX-31.2 d49187dex312.htm EX-31.2 10723
4 EX-32 d49187dex32.htm EX-32 5329
  Complete submission text file 0001193125-20-328763.txt   5551957

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA neog-20201130.xsd EX-101.SCH 35159
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neog-20201130_cal.xml EX-101.CAL 37365
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neog-20201130_def.xml EX-101.DEF 266793
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE neog-20201130_lab.xml EX-101.LAB 330417
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neog-20201130_pre.xml EX-101.PRE 303733
10 EXTRACTED XBRL INSTANCE DOCUMENT d49187d10q_htm.xml XML 1043259
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 201423218
SIC: 2835 In Vitro & In Vivo Diagnostic Substances